Vascularized Deep Femoral Periosteal Flap: Anatomical Study and Clinical Application in Congenital Pseudarthrosis of the Tibia in Two Cases
Microsurgery · 2025
DOI: 10.1002/micr.70043 ↗Kurz gefasst
Fallbericht in der Zeitschrift Microsurgery, 2025. Verfasst von Antonio Carlos da Costa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Orthopaedic and Traumatology Surgery Department, Santa Casa de Sao Paulo, Hand Surgery and Microsurgery Group, Sao Paulo, Brazil. Hauptthemen laut MEDLINE: Pseudarthrosis, Femur, Periosteum, Surgical Flaps. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Background
Vascularized periosteal transplants have proven to be highly effective and rapid in promoting bone healing in biologically complex nonunions in children, with several reported donor sites. This study aimed to assess the feasibility of harvesting a vascularized diaphyseal femoral periosteal flap (VDFPF) from cadavers and evaluate its clinical application in two cases of bilateral congenital pseudarthrosis of the tibia.
Methods
This study investigated the periosteal branches of the deep femoral vessels (DFV) supplying the femoral diaphysis in 19 previously latex‐injected cadavers. The femur was divided into four segments. The distance from the midpoint of the inguinal ligament to the origin of the DFV and the number of periosteal branches were recorded. The vascularized diaphyseal femoral periosteal flap (VDFPF) was used to treat one side in two patients with bilateral congenital pseudarthrosis of the tibia (aged 14 and 2 years).
Results
The DFV's origin was located at a mean of 4.2 cm (range 2.8–8.5 cm) distal to the midpoint of the inguinal ligament. In 15 cases, the DFV coursed adjacent to the second and third quarters of the femoral shaft, providing a mean number of 5 (range 4–8) periosteal branches, allowing for the harvesting of a new pure vascularized periosteal flap. Healing of congenital pseudarthrosis of the tibia occurred within 3 months in both patients, with no donor or recipient site complications at the final follow‐up of 13 months.
Conclusions
The VDFPF may be an effective periosteal transplant and a viable alternative to other large free periosteal transplants used in children for treating complex non‐unions, especially when tibial and fibular donors are not available. Bone union was fast compared to other techniques used to treat these challenging cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Orthopaedic and Traumatology Surgery Department, Santa Casa de Sao Paulo, Hand Surgery and Microsurgery Group, Sao Paulo, Brazil.
- Pediatric Orthopaedic Surgery, San Juan de Dios Clinic, Lima, Peru.
- Hand Surgery and Microsurgery Department, Farallones Clinic, Christus Health, Cali, Colombia.
- Pontificia Javeriana University, Cali, Colombia.
- Orthopaedic Surgery Department, Hospital Universitari Vall d'Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain.
- Hand Surgery Department, Shifa Hospital, Al-Azhar University, Cairo, Egypt.
ORCID-Profile: Diego Gonzalez-Morgado
Zitieren
APA
da Costa, A. C., Romero-Larrauri, P., Rojas-Neira, J., Gonzalez-Morgado, D., Fouad, A., Alves, C., & Soldado, F. (2025). Vascularized Deep Femoral Periosteal Flap: Anatomical Study and Clinical Application in Congenital Pseudarthrosis of the Tibia in Two Cases. Microsurgery. https://doi.org/10.1002/micr.70043
Vancouver
da Costa AC, Romero-Larrauri P, Rojas-Neira J, Gonzalez-Morgado D, Fouad A, Alves C, et al. Vascularized Deep Femoral Periosteal Flap: Anatomical Study and Clinical Application in Congenital Pseudarthrosis of the Tibia in Two Cases. Microsurgery. 2025. doi:10.1002/micr.70043
BibTeX
@article{daCosta2025,
author = {da Costa, Antonio Carlos and Romero-Larrauri, Pablo and Rojas-Neira, Juliana and Gonzalez-Morgado, Diego and Fouad, Amr and Alves, Cristina and Soldado, Francisco},
title = {Vascularized Deep Femoral Periosteal Flap: Anatomical Study and Clinical Application in Congenital Pseudarthrosis of the Tibia in Two Cases},
journal = {Microsurgery},
year = {2025},
doi = {10.1002/micr.70043}
}
EUVIMED